STAAR SURGICAL CO (STAA) Fundamental Analysis & Valuation

NASDAQ:STAA • US8523123052

17.66 USD
+0.43 (+2.5%)
At close: Mar 11, 2026
17.69 USD
+0.03 (+0.17%)
Pre-Market: 3/12/2026, 4:25:38 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This STAA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall STAA gets a fundamental rating of 4 out of 10. We evaluated STAA against 184 industry peers in the Health Care Equipment & Supplies industry. STAA has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, STAA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. STAA Profitability Analysis

1.1 Basic Checks

  • In the past year STAA has reported negative net income.
  • STAA had a negative operating cash flow in the past year.
  • In multiple years STAA reported negative net income over the last 5 years.
  • Of the past 5 years STAA 4 years had a positive operating cash flow.
STAA Yearly Net Income VS EBIT VS OCF VS FCFSTAA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -17.81%, STAA perfoms like the industry average, outperforming 53.80% of the companies in the same industry.
  • STAA has a Return On Equity (-23.37%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -17.81%
ROE -23.37%
ROIC N/A
ROA(3y)-5.8%
ROA(5y)-0.19%
ROE(3y)-7.64%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
STAA Yearly ROA, ROE, ROICSTAA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • STAA has a Gross Margin of 76.19%. This is amongst the best in the industry. STAA outperforms 86.41% of its industry peers.
  • STAA's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for STAA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y1.02%
STAA Yearly Profit, Operating, Gross MarginsSTAA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. STAA Health Analysis

2.1 Basic Checks

  • STAA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, STAA has more shares outstanding
  • Compared to 5 years ago, STAA has more shares outstanding
  • STAA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
STAA Yearly Shares OutstandingSTAA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
STAA Yearly Total Debt VS Total AssetsSTAA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 5.28 indicates that STAA is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.28, STAA is in the better half of the industry, outperforming 79.89% of the companies in the same industry.
  • There is no outstanding debt for STAA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.28
ROIC/WACCN/A
WACC9.9%
STAA Yearly LT Debt VS Equity VS FCFSTAA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 4.55 indicates that STAA has no problem at all paying its short term obligations.
  • STAA's Current ratio of 4.55 is fine compared to the rest of the industry. STAA outperforms 71.20% of its industry peers.
  • STAA has a Quick Ratio of 3.74. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.74, STAA is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 3.74
STAA Yearly Current Assets VS Current LiabilitesSTAA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. STAA Growth Analysis

3.1 Past

  • The earnings per share for STAA have decreased strongly by -421.21% in the last year.
  • STAA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.72%.
  • STAA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.93% yearly.
EPS 1Y (TTM)-421.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26%
Revenue 1Y (TTM)-23.72%
Revenue growth 3Y-5.57%
Revenue growth 5Y7.93%
Sales Q2Q%18.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 34.48% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, STAA will show a quite strong growth in Revenue. The Revenue will grow by 13.36% on average per year.
EPS Next Y113.33%
EPS Next 2Y61.1%
EPS Next 3Y36.59%
EPS Next 5Y34.48%
Revenue Next Year22%
Revenue Next 2Y14.87%
Revenue Next 3Y12.7%
Revenue Next 5Y13.36%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STAA Yearly Revenue VS EstimatesSTAA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
STAA Yearly EPS VS EstimatesSTAA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

2

4. STAA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for STAA. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 124.95, which means the current valuation is very expensive for STAA.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of STAA indicates a somewhat cheap valuation: STAA is cheaper than 64.13% of the companies listed in the same industry.
  • STAA is valuated expensively when we compare the Price/Forward Earnings ratio to 24.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 124.95
STAA Price Earnings VS Forward Price EarningsSTAA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STAA Per share dataSTAA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as STAA's earnings are expected to grow with 36.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.1%
EPS Next 3Y36.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STAA Dividend Analysis

5.1 Amount

  • No dividends for STAA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STAA Fundamentals: All Metrics, Ratios and Statistics

STAAR SURGICAL CO

NASDAQ:STAA (3/11/2026, 8:26:14 PM)

Premarket: 17.69 +0.03 (+0.17%)

17.66

+0.43 (+2.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-03
Earnings (Next)05-05
Inst Owners108.81%
Inst Owner Change1.46%
Ins Owners0.31%
Ins Owner Change148.03%
Market Cap878.41M
Revenue(TTM)239.44M
Net Income(TTM)-80.45M
Analysts52.5
Price Target23.15 (31.09%)
Short Float %11.59%
Short Ratio3.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-362.76%
Min EPS beat(2)-734.84%
Max EPS beat(2)9.32%
EPS beat(4)3
Avg EPS beat(4)-165.83%
Min EPS beat(4)-734.84%
Max EPS beat(4)49.58%
EPS beat(8)6
Avg EPS beat(8)-476.9%
EPS beat(12)8
Avg EPS beat(12)-310.53%
EPS beat(16)12
Avg EPS beat(16)-209.31%
Revenue beat(2)1
Avg Revenue beat(2)-11.28%
Min Revenue beat(2)-24.81%
Max Revenue beat(2)2.26%
Revenue beat(4)3
Avg Revenue beat(4)-2.67%
Min Revenue beat(4)-24.81%
Max Revenue beat(4)8.25%
Revenue beat(8)5
Avg Revenue beat(8)-5.77%
Revenue beat(12)6
Avg Revenue beat(12)-3.68%
Revenue beat(16)7
Avg Revenue beat(16)-2.83%
PT rev (1m)-2.85%
PT rev (3m)-7.84%
EPS NQ rev (1m)-7.35%
EPS NQ rev (3m)-13.42%
EPS NY rev (1m)1.76%
EPS NY rev (3m)11.78%
Revenue NQ rev (1m)-0.71%
Revenue NQ rev (3m)-0.8%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 124.95
P/S 3.67
P/FCF N/A
P/OCF N/A
P/B 2.55
P/tB 2.82
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)0.14
Fwd EY0.8%
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS4.81
BVpS6.92
TBVpS6.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.81%
ROE -23.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.19%
FCFM N/A
ROA(3y)-5.8%
ROA(5y)-0.19%
ROE(3y)-7.64%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y1.02%
F-Score3
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.68%
Cap/Sales 2.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 3.74
Altman-Z 5.28
F-Score3
WACC9.9%
ROIC/WACCN/A
Cap/Depr(3y)253.71%
Cap/Depr(5y)307.54%
Cap/Sales(3y)5.17%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-421.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26%
EPS Next Y113.33%
EPS Next 2Y61.1%
EPS Next 3Y36.59%
EPS Next 5Y34.48%
Revenue 1Y (TTM)-23.72%
Revenue growth 3Y-5.57%
Revenue growth 5Y7.93%
Sales Q2Q%18.08%
Revenue Next Year22%
Revenue Next 2Y14.87%
Revenue Next 3Y12.7%
Revenue Next 5Y13.36%
EBIT growth 1Y-264.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year153.88%
EBIT Next 3Y42.24%
EBIT Next 5Y27.01%
FCF growth 1Y-422.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-317.68%
OCF growth 3YN/A
OCF growth 5YN/A

STAAR SURGICAL CO / STAA FAQ

What is the fundamental rating for STAA stock?

ChartMill assigns a fundamental rating of 4 / 10 to STAA.


Can you provide the valuation status for STAAR SURGICAL CO?

ChartMill assigns a valuation rating of 2 / 10 to STAAR SURGICAL CO (STAA). This can be considered as Overvalued.


What is the profitability of STAA stock?

STAAR SURGICAL CO (STAA) has a profitability rating of 2 / 10.


How financially healthy is STAAR SURGICAL CO?

The financial health rating of STAAR SURGICAL CO (STAA) is 8 / 10.